A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00543920

Enrollment

Registered

2007-10-15

Start date

2002-08-31

Completion date

2003-02-28

Last updated

2015-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders

Brief summary

The study will look at the effect of MK0777on reducing anxiety in subjects with general anxiety disorder. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

Interventions

DRUGMK0777

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Diagnosis of General Anxiety Order

Exclusion criteria

* Women who are pregnant or breast-feeding * History of severe drug reaction * History of severe drug withdrawal symptoms such as seizures or delirium * Disease of cardiovascular system * Disease of the liver, kidneys, endocrine system, metabolic system or eyes * History of seizures or seizure disorder * History of drug or alcohol abuse

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026